765302-70-3

Basic information

• Product Name: (4-chloro-3-hydroxy-phenyl)-acetic acid ethyl ester
• Synonyms: (4-chloro-3-hydroxy-phenyl)-acetic acid ethyl ester
• CAS NO: 765302-70-3
• Molecular Weight: 214.649
• Mol File: 765302-70-3.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: (4-chloro-3-hydroxy-phenyl)-acetic acid ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: (4-chloro-3-hydroxy-phenyl)-acetic acid ethyl ester(765302-70-3)
• EPA Substance Registry System: (4-chloro-3-hydroxy-phenyl)-acetic acid ethyl ester(765302-70-3)

Safety Data

• Hazardous Substances Data: 765302-70-3(Hazardous Substances Data)

Upstream product

• 60397-70-8 2-(4-chloro-3-hydroxyphenyl)acetic acid 
• 64-17-5 ethanol 
• 867366-60-7 ethyl 4-chloro-3-methoxyphenylmethylimidate hydrochloride 
• 96042-30-7 4-(dicyanomethylene)-2-methyl-6-(p-dimethylaminostyryl)-4H-pyran 
• 73909-16-7 2-chloro-5-methylanisole 
• 1056987-17-7 ethyl 4-chloro-3-methoxyphenylacetate 

Downstream Products

• 928017-72-5 C₂₄H₂₆Cl₂N₂O₃S 
• 934241-70-0 ethyl {4-chloro-3-[2-chloro-4-(methylsulfonyl)phenoxy]phenyl}acetate 
• 1056155-67-9 C₁₉H₁₈ClNO₃ 
• 770719-36-3 C₁₇H₁₃Cl₂NO₃ 
• 770718-74-6 C₁₆H₁₅Cl₂NO₃ 
• 770718-72-4 C₁₆H₁₂Cl₂N₂O₃ 
• 765302-71-4 ethyl 4-chloro-3-(3-cyano-5-fluorophenoxy)phenylacetate 
• 770719-26-1 C₁₄H₁₉ClO₅ 
• 770718-63-3 C₁₄H₁₉ClO₃ 

Relevant articles and documents

ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS

Described herein are compounds that are antagonists of PGD2 receptors. Also described are pharmaceutical compositions that include the compounds described herein, and methods of using such antagonists of PGD2 receptors, alone or in combination with other compounds, for treating respiratory, cardiovascular, and other PGD2-dependent or PGD2-mediated conditions or diseases.

Substituted Diphenylethers, -Amines, -Sulfides and -Methanes for the Treatment of Respiratory Disease

The invention relates to substituted diphenylethers, -amines, -sulfides, and -methanes as useful pharmaceutical compounds for treating respiratory-disorders, pharmaceutical compositions containing them, and processes for their preparation.

Non-nucleoside reverse transcriptase inhibitors

The present invention provides compounds for treating or preventing an HIV infection, or treating AIDS or ARC comprising administering a compound according to formula I where Ar, R1-R5, R7a, R7b, R7c, R8-R10, X1, X2 m, n, o and p are as defined herein.